Research around CJC-1295 and Ipamorelin includes experimental, investigational, and limited human-interest discussion, but evidence quality, clinical standards, and regulatory context can vary
W., Mathew, R
Its proposed mechanism of action involves interaction with GHS receptors, also known as ghrelin receptors, which are found in the pituitary and hypothalamus
Quick Takeaways Tesamorelin has robust clinical evidence for reducing visceral fat (15-17.5%), increasing lean mass (1.42 kg), and improving metabolic markers in human trials Ipamorelin selectively releases growth hormone without affecting cortisol or prolactin, making it the cleanest GHRP available Combining a GHRH with a GHRP creates synergistic GH pulsatility that mimics and amplifies your bodys natural growth hormone patterns My recommended protocol: Tesamorelin 1mg + Ipamorelin 100mcg, injected AM/PM, 5 days on/2 days off, 8 weeks on/8 weeks off What This Peptide Combination Actually Is Tesamorelin and Ipamorelin target different receptors in the growth hormone regulation system, which is precisely why they work so well together
Let us help you unlock your best self with the help of science.
SchnelleMCatibogNZhangMNabeebaccusAAAndersonGRichardsDAet alEchocardiographic evaluation of diastolic function in mouse models of heart disease